mDPR-Val-Cit-PAB-MMAE TFA is a drug-linker conjugate for ADC ( Drug-Linker Conjugates for ADC ), consisting of a tubulin polymerization inhibitor MMAE ( HY-15162 ) and an ADC linker (peptide Val-Cit- PAB) composition [1] .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Drug-Linker Conjugates for ADC
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。